High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers

被引:11
|
作者
Tokunaga, Eriko [1 ]
Okada, Satoko [1 ]
Yamashita, Nami [1 ]
Akiyoshi, Sayuri [1 ]
Kitao, Hiroyuki [2 ]
Morita, Masaru [1 ]
Kakeji, Yoshihiro [1 ]
Maehara, Yoshihiko [1 ]
机构
[1] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka 8128582, Japan
关键词
Loss of heterozygosity; Human epidermal receptor-2; Triple-negative breast cancer; Genetic instability; Breast cancer subtype; FLUORESCENT MICROSATELLITE ANALYSIS; DINUCLEOTIDE REPEAT INSTABILITY; DNA MISMATCH REPAIR; GENOME-WIDE SEARCH; PROGESTERONE-RECEPTOR; GASTRIC-CANCER; HETEROZYGOSITY; EXPRESSION; CARCINOMA; BRCA1;
D O I
10.1007/s12282-010-0232-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Basal-like and HER2-overexpressing breast carcinomas are histologically undifferentiated, high-grade tumors with a high proliferation rate and associated with a poor outcome. Most basal-like tumors lack the expression of ER, PR, and HER2 (triple-negative; TN). Loss of heterozygosity (LOH) is thought to reflect random chromosomal instability, and recent studies have shown that DNA-copy number alterations or LOH occur with a high frequency in basal-like and HER2-amplified tumors. The levels and patterns of LOH were analyzed by the microsatellite alteration analysis using fluorescence-labeled primers and an automated DNA sequencer at 5 randomly selected loci in 246 Japanese primary breast cancers. Associations between the level of LOH and breast cancer subtypes and tumor aggressiveness were investigated. The incidence and frequency of LOH was significantly higher in HER2 (56.3, 26.7%) and TN groups (44.4, 27.1%) than in luminal A (ER-positive and/or PR-positive and HER2-negative) groups (32.0, 12.2%). The incidence and frequency of LOH increased as nuclear grade was elevated. There were significantly more grade 3 tumors in the HER2 (80.0%) and TN (68.2%) subgroups (p < 0.0001). Even in HER2 and TN cases, the incidence and frequency of LOH was significantly higher in nuclear grade 3 cases than in grade 1 or 2 cases. Relapse-free survival of patients with LOH was significantly shorter than for those without LOH. In addition, the survival time was shorter as the frequency of LOH elevated. The incidence of LOH was an independent prognostic factor for relapse-free survival by multivariate analysis. High incidence and frequency of LOH, which indicate increased genetic instability, were found to be associated with the aggressive features of high-grade HER2 and TN breast cancers.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 50 条
  • [31] High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis
    Yuan, Zhong-Yu
    Luo, Rong-Zhen
    Peng, Rou-Jun
    Wang, Shu-Sen
    Xue, Cong
    ONCOTARGETS AND THERAPY, 2014, 7 : 1 - 6
  • [32] PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy
    Grandal, Beatriz
    Mangiardi-Veltin, Manon
    Laas, Enora
    Lae, Marick
    Meseure, Didier
    Bataillon, Guillaume
    El-Alam, Elsy
    Darrigues, Lauren
    Dumas, Elise
    Daoud, Eric
    Vincent-Salomon, Anne
    Talagrand, Laure-Sophie
    Pierga, Jean-Yves
    Reyal, Fabien
    Hamy, Anne-Sophie
    CANCERS, 2021, 13 (04) : 1 - 17
  • [33] p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?
    Wang, Xi
    Stolla, Moritz
    Ring, Brian Z.
    Yang, Qi
    Laughlin, Todd S.
    Rothberg, Paul G.
    Skinner, Kristin
    Hicks, David G.
    HUMAN PATHOLOGY, 2016, 55 : 196 - 201
  • [34] Predictive factors of pathologically node-negative disease for HER2 positive and triple-negative breast cancer after neoadjuvant therapy
    Shi, Zhiqiang
    Wang, Xueer
    Qiu, Pengfei
    Liu, Yanbing
    Zhao, Tong
    Sun, Xiao
    Chen, Peng
    Wang, Chunjian
    Zhang, Zhaopeng
    Cong, Binbin
    Wang, Yongsheng
    GLAND SURGERY, 2021, 10 (01) : 166 - 174
  • [35] Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype
    Jeong, Hoiseon
    Ryu, Young-joon
    An, Jungsuk
    Lee, Youngseok
    Kim, Aeree
    HISTOPATHOLOGY, 2012, 60 (6B) : E87 - E95
  • [36] Impact of HER2 status on clinicopathological characteristics and pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Shi, Yue
    Lu, Heng
    Zhang, Yiqi
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (02) : 387 - 395
  • [37] ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer
    Nagel, Anna
    Popeda, Marta
    Muchlinska, Anna
    Sadej, Rafal
    Szade, Jolanta
    Zielinski, Jacek
    Skokowski, Jaroslaw
    Niemira, Magdalena
    Kretowski, Adam
    Markiewicz, Aleksandra
    Zaczek, Anna J.
    CANCERS, 2022, 14 (08)
  • [38] Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers
    Kaur, Jaspreet
    Chandrashekar, Darshan S.
    Varga, Zsuzsanna
    Sobottka, Bettina
    Janssen, Emiel
    Gandhi, Khanjan
    Kowalski, Jeanne
    Kiraz, Umay
    Varambally, Sooryanarayana
    Aneja, Ritu
    GENES, 2023, 14 (09)
  • [39] Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15
    Lehmann-Che, Jacqueline
    Hamy, Anne-Sophie
    Porcher, Raphael
    Barritault, Marc
    Bouhidel, Fatiha
    Habuellelah, Hanadi
    Leman-Detours, Solenne
    de Roquancourt, Anne
    Cahen-Doidy, Laurence
    Bourstyn, Edwige
    de Cremoux, Patricia
    de Bazelaire, Cedric
    Albiter, Marcela
    Giacchetti, Sylvie
    Cuvier, Caroline
    Janin, Anne
    Espie, Marc
    de The, Hugues
    Bertheau, Philippe
    BREAST CANCER RESEARCH, 2013, 15 (03)
  • [40] High Level of CXCR4 in Triple-Negative Breast Cancer Specimens Associated with a Poor Clinical Outcome
    Yu, Shaonan
    Wang, Xiaozhen
    Liu, Guifeng
    Zhu, Xuewei
    Chen, Yan
    ACTA MEDICA OKAYAMA, 2013, 67 (06) : 369 - 375